Project Grant R01DK144183
Award Date 9/1/26
Completion Date 5/31/30
Dollars Obligated $335K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Kansas City, KS 66160, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $620,185 to the University of Oklahoma Health Sciences Center on April 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate polycystin 1 function as a G protein-coupled receptor in autosomal dominant polycystic kidney disease pathogenesis. The research project, titled "Defining the Role of Polycystin 1 as a G Protein Coupled Receptor in Kidney...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the Regents of the University of California, San Francisco $790,063 on March 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to functionally characterize pathogenic variants in polycystin-1 (PC1) and develop therapeutic interventions for autosomal dominant polycystic kidney disease (ADPKD). The project, R01DK146478, will quantify the effects of PC1 missense mutations...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York (operating as Stony Brook University) $785,689 on August 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify the therapeutic potential and molecular mechanism of the long noncoding RNA HOXB3OS in autosomal dominant polycystic kidney disease. The research addresses the incompletely understood...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Augusta University Research Institute, Inc. $645,382 on March 1, 2026, to investigate the role of netrin-1 in polycystic kidney disease progression under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research addresses mechanisms of autosomal dominant polycystic kidney disease (ADPKD), which causes fluid-filled cysts in kidney tubules and progression to end-stage renal...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a cooperative agreement totaling $803,534 to the University of Washington on September 15, 2025, to establish the Polycystic Kidney Disease In Vitro Center (PKD-INVENT) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). PKD-INVENT will expand the preclinical-to-clinical research pathway for polycystic kidney disease by developing and providing human PKD organoids and related...
- The National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health within the Department of Health and Human Services, awarded Children's Research Institute $156,814 on August 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support Project Grant K08DK149197. The award funds research defining immunomodulatory mechanisms in autosomal recessive polycystic kidney disease (ARPKD), a severe...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Regents of the University of California, San Francisco $191,700 on January 11, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate how membrane lipids mediate ciliary signaling in polycystic kidney disease. The research addresses the role of phosphatidylserine, a membrane lipid, in regulating the polycystin complex within the primary cilium. Mutations...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Oklahoma Health Sciences Center $124,842 under Project Grant F31DK146691 on June 19, 2026, to fund research into the role of interferon gamma in injury-accelerated cystic kidney disease. The award supports basic biomedical research examining how kidney injury promotes rapid progression of polycystic kidney disease (PKD) in patients with mutations in cilia-related genes. The investigator will test the...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a cooperative agreement to Mayo Clinic on September 22, 2025, for $561,335 to establish and operate the Mayo Clinic Polycystic Kidney Disease Research Core Center (MPRC), which provides reagents, biological materials, phenotyping data, and expertise to the polycystic kidney disease research community through the PKD-Research Resource Consortium. The MPRC operates three cores. The Human ADPKD Population and Materials...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a Cooperative Agreement totaling $611,688 to Weill Medical College of Cornell University on September 12, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop an AI-based image phenotyping core for autosomal dominant polycystic kidney disease (ADPKD) research. The recipient will establish a biomedical research core that comprehensively labels and annotates...